209 related articles for article (PubMed ID: 31355688)
1. Pharmacotherapeutic approaches to treating depression during the perimenopause.
Garay RP; Charpeaud T; Logan S; Hannaert P; Garay RG; Llorca PM; Shorey S
Expert Opin Pharmacother; 2019 Oct; 20(15):1837-1845. PubMed ID: 31355688
[No Abstract] [Full Text] [Related]
2. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations.
Maki PM; Kornstein SG; Joffe H; Bromberger JT; Freeman EW; Athappilly G; Bobo WV; Rubin LH; Koleva HK; Cohen LS; Soares CN
J Womens Health (Larchmt); 2019 Feb; 28(2):117-134. PubMed ID: 30182804
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations.
Maki PM; Kornstein SG; Joffe H; Bromberger JT; Freeman EW; Athappilly G; Bobo WV; Rubin LH; Koleva HK; Cohen LS; Soares CN;
Menopause; 2018 Oct; 25(10):1069-1085. PubMed ID: 30179986
[TBL] [Abstract][Full Text] [Related]
4. Lack of association of acute phase response proteins with hormone levels and antidepressant medication in perimenopausal depression.
Karaoulanis SE; Rizouli KA; Rizoulis AA; Angelopoulos NV
BMC Psychiatry; 2014 Jun; 14():164. PubMed ID: 24894416
[TBL] [Abstract][Full Text] [Related]
5. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
[TBL] [Abstract][Full Text] [Related]
6. Perimenopause and depression: strength of association, causal mechanisms and treatment recommendations.
Gyllstrom ME; Schreiner PJ; Harlow BL
Best Pract Res Clin Obstet Gynaecol; 2007 Apr; 21(2):275-92. PubMed ID: 17166771
[TBL] [Abstract][Full Text] [Related]
7. The Expert Consensus Guideline Series. Treatment of depression in women.
Altshuler LL; Cohen LS; Moline ML; Kahn DA; Carpenter D; Docherty JP;
Postgrad Med; 2001 Mar; (Spec No):1-107. PubMed ID: 11500997
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
9. Hormonal therapies for new onset and relapsed depression during perimenopause.
Worsley R; Davis SR; Gavrilidis E; Gibbs Z; Lee S; Burger H; Kulkarni J
Maturitas; 2012 Oct; 73(2):127-33. PubMed ID: 22824374
[TBL] [Abstract][Full Text] [Related]
10. Symptoms assessed in studies on perimenopausal depression: A narrative review.
Willi J; Ehlert U
Sex Reprod Healthc; 2020 Dec; 26():100559. PubMed ID: 33010665
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review.
Toffol E; Heikinheimo O; Partonen T
Menopause; 2015 May; 22(5):564-78. PubMed ID: 25203891
[TBL] [Abstract][Full Text] [Related]
12. Bioidentical Estrogen for Menopausal Depressive Symptoms: A Systematic Review and Meta-Analysis.
Whedon JM; KizhakkeVeettil A; Rugo NA; Kieffer KA
J Womens Health (Larchmt); 2017 Jan; 26(1):18-28. PubMed ID: 27603786
[TBL] [Abstract][Full Text] [Related]
13. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
Thorkelson G; Bielefeldt K; Szigethy E
Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
[TBL] [Abstract][Full Text] [Related]
14. Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone.
Kulkarni J; Gavrilidis E; Thomas N; Hudaib AR; Worsley R; Thew C; Bleeker C; Gurvich C
J Affect Disord; 2018 Aug; 236():88-92. PubMed ID: 29723767
[TBL] [Abstract][Full Text] [Related]
15. Assessment of perimenopausal depression: A review.
Willi J; Ehlert U
J Affect Disord; 2019 Apr; 249():216-222. PubMed ID: 30776662
[TBL] [Abstract][Full Text] [Related]
16. Escitalopram for perimenopausal depression: an open-label pilot study.
Freeman MP; Hill R; Brumbach BH
J Womens Health (Larchmt); 2006 Sep; 15(7):857-61. PubMed ID: 16999641
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
18. Depression or menopause? Presentation and management of major depressive disorder in perimenopausal and postmenopausal women.
Clayton AH; Ninan PT
Prim Care Companion J Clin Psychiatry; 2010; 12(1):PCC.08r00747. PubMed ID: 20582297
[TBL] [Abstract][Full Text] [Related]
19. Optimal management of perimenopausal depression.
Parry BL
Int J Womens Health; 2010 Aug; 2():143-51. PubMed ID: 21072307
[TBL] [Abstract][Full Text] [Related]
20. Missed symptoms of menopause.
Warren MP
Int J Clin Pract; 2007 Dec; 61(12):2041-50. PubMed ID: 17892470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
